448 related articles for article (PubMed ID: 37079114)
1. Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review.
Babu A; Ramanathan G
Funct Integr Genomics; 2023 Apr; 23(2):130. PubMed ID: 37079114
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics.
Pei CZ; Jin L; Baek KH
Biomed Pharmacother; 2021 Oct; 142():112031. PubMed ID: 34411918
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the DNA Methylome of Polycystic Ovary Syndrome.
Tan Q
Mol Diagn Ther; 2020 Jun; 24(3):245-250. PubMed ID: 32297305
[TBL] [Abstract][Full Text] [Related]
4. Multiomics Analysis-Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome.
Rani S; Chandna P
Reprod Sci; 2023 Jan; 30(1):1-27. PubMed ID: 35084716
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Marks in Polycystic Ovary Syndrome.
Motta AB
Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome.
Jing T; Wu Y; Wan A; Ge C; Chen ZJ; Du Y
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509138
[TBL] [Abstract][Full Text] [Related]
7. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
[TBL] [Abstract][Full Text] [Related]
8. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review.
Atiomo W; Khalid S; Parameshweran S; Houda M; Layfield R
BJOG; 2009 Jan; 116(2):137-43. PubMed ID: 19076945
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
Chen Z; Ou H; Wu H; Wu P; Mo Z
DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.
Xu J; Bao X; Peng Z; Wang L; Du L; Niu W; Sun Y
Oncotarget; 2016 May; 7(19):27899-909. PubMed ID: 27056885
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
[TBL] [Abstract][Full Text] [Related]
12. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
[TBL] [Abstract][Full Text] [Related]
13. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.
Stener-Victorin E; Deng Q
Nat Rev Endocrinol; 2021 Sep; 17(9):521-533. PubMed ID: 34234312
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA
Li Y; Zhang J; Liu YD; Zhou XY; Chen X; Zhe J; Zhang QY; Zhang XF; Chen YX; Wang Z; Chen SL
RNA Biol; 2020 Dec; 17(12):1798-1810. PubMed ID: 32559120
[TBL] [Abstract][Full Text] [Related]
16. 3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples.
Xie L; Jiang X; Chen Y; Huang C; Chen Y; Liu G; Sun W; Zeng L; Lu R
Comb Chem High Throughput Screen; 2022; 25(8):1304-1313. PubMed ID: 34080962
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
[TBL] [Abstract][Full Text] [Related]
18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing.
Fu LL; Xu Y; Li DD; Dai XW; Xu X; Zhang JS; Ming H; Zhang XY; Zhang GQ; Ma YL; Zheng LW
Gene; 2018 May; 657():19-29. PubMed ID: 29505837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
